Pozza, M <br/><br/>
Further evidence for a role of nitric oxide in experimental allergic encephalomyelitis: aminoguanidine treatment modifies its clinical evolution.  [electronic resource] 

 -  Brain research  Feb 2000 
 - 39-46 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0006-8993 
<br/><br/><label>Standard No.: </label>10.1016/s0006-8993(99)02133-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Animals<br/>Brain--enzymology<br/>Demyelinating Diseases--enzymology<br/>Disease Progression<br/>Encephalomyelitis, Autoimmune, Experimental--drug therapy<br/>Enzyme Inhibitors--pharmacology<br/>Female<br/>Guanidines--pharmacology<br/>Nitric Oxide--physiology<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Rats<br/>Rats, Inbred Lew<br/>Specific Pathogen-Free Organisms